CLINICAL CHEMISTRY ANTI-CCP
ACTIVE-B12
HBA1C
HEPARIN BINDING PROTEIN
ANTI-CCP ELISA
HOMOCYSTEINE EIA
ENZYMATIC HOMOCYSTEINE
SYPHSCREEN RPR
MICROSYPH TPHA
OEM
At Axis-Shield, innovation is fundamental to our business.
Our expertise encompasses the development of novel proprietary diagnostic tests in areas of clinical need and their incorporation onto the menus of the high throughput analysers of our partners, using a variety of assay technologies.
We specialise in unique markers for the early diagnosis and management of critical illnesses:
Cardiovascular and neurodegenerative diseases
Rheumatoid Arthritis
Sepsis
Vitamin deficiencies
Diabetes
Our proprietary tests and technologies to measure HbA1c, Homocysteine, anti-CCP (for early detection of rheumatoid arthritis) and Active-B12 (for better detection of vitamin B12 deficiency) are driving revenues and there has also been much interest in our newer markers such as Heparin Binding Protein for diagnosis and prediction of severe sepsis.